X
Get new exclusive access to healthcare business reports & breaking news
Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.
Swiss-based biotech company, Therachon, which focuses on developing rare genetic disease treatments, says it has closed a $60 ...
A new biotechnology company, Ambys Medicines, which is developing regenerative medicines for liver disease, recently raised $60 million ...
Drugmaker Samumed last week announced that it had closed its A-6 round of equity issuance with $438 million ...
The state of Illinois faces another lawsuit over the wrongful death of a veteran after reported Legionnaire’s disease ...
A Series C funding round by SQZ Biotech – a cell therapy firm developing new treatments for ...
The Illinois Department of Public Health (IDPH) has announced that the prevalence of hepatitis C infections in the ...
A task force to modernize Illinois’ telemedicine policies in order to improve quality and access to care is ...
